ABL Europe Enters into a Collaboration for the GMP Manufacture of Hookipa Biotech's Heterologous Viral Vector Immunotherapy Platform

VIENNA, Austria and STRASBOURG, France, February 27, 2018 /PRNewswire/ -- Hookipa Biotech AG, a clinical stage biotech company aiming to develop best-in-class active immunization therapies for infectious diseases and oncology, and ABL Europe SAS, an ABL Inc. company providing...

from PR Newswire: //http://ift.tt/2BTq7mP